Eli Lilly asked to turn over Zyprexa promotion info

Eli Lilly has been asked by state prosecutors in Illinois and Vermont to turn over info about the way it promoted Zyprexa, its antipsychotic drug. The states are investigating whether Lilly tried to hide Zyprexa's risk of causing weight gain and other risks associated with diabetes and whether the company promoted it for off-label uses. Lilly said it would cooperate with the investigations and had done nothing wrong.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions